Overall rank by patents
#6,455
of 50,000 tracked assignees
USPTO PatentsView assignee record - 52 granted patents across 18 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE).
The verdict
According to USPTO PatentsView, Lanzatech ranks #6,455 of 50,000 tracked US assignees by granted-patent volume, with 52 patents across 18 technology areas.
USPTO PatentsView assignee plate
Corpus R6455 · US Corporation #6,455 · 52 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Kala Pharmaceuticals, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Freudenberg-nok Gene… · near
38 score
IPEX · near
38 score
Lanzatech New Zealand · this assignee
38 score
NL Giken Incorporated · near
38 score
Obrist Closures Swit… · near
38 score
3D Lighting Innovati… · lowest
7 score
What this shows Lanzatech New Zealand Limited stamps GRANTS-SMALL, UPPER-Q, PHOTO-FINISH, CPC-FOCUS, INNOV-THIN, CLAIMS-RICH, TYPE-USCORP, VEL-DROP, BOOK-FULL. Volume places it #6,455 of 50,000; Innovation Score 38.4/100 sits in the top 41% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Kala Pharmaceuticals, Inc. (±0 grants).
Lanzatech New Zealand Limited has been granted 52 US utility patents between 2015 and 2022, placing Lanzatech New Zealand Limited at #6,455 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in C12P (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE). As a US Corporation, Lanzatech New Zealand Limited is one of the more focused assignees in the PatentsView dataset. By volume, Lanzatech sits between Kyowa Hakko BIO Co., Ltd. (52 patents, rank #6,451) and MAN Diesel & Turbo SE (52 patents, rank #6,459) - the closest US assignees by grant volume. The composite Innovation Score of 38.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 10 grants, compared with 42 in the 2015–2019 window, a -76% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Lanzatech New Zealand Limited's 15.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 18 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KYOWA HAKKO BIO CO., LTD.
52 patents
KYUSHU UNIVERSITY
52 patents
Kala Pharmaceuticals, Inc.
52 patents
King Furniture Australia Pty Ltd.
52 patents
Limagrain Europe S.A.
52 patents
Lumson S.p.A.
52 patents
M31 TECHNOLOGY CORPORATION
52 patents
MAN Diesel & Turbo SE
52 patents
LanzaTech New Zealand Limited
52 patents
What this shows Lanzatech holds 52 patents at rank #6,455, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,455 in granted patent volume.
Other assignees with the most granted patents in Lanzatech's primary technology class.
Two PlainPatent-derived peer sets for Lanzatech, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (38 here).
Nearest assignees by average claims per patent (15.4 here).
Lanzatech's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 41% higher than 59% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 7.7% |
| 2016 | 11 | 21.2% |
| 2017 | 11 | 21.2% |
| 2018 | 8 | 15.4% |
| 2019 | 8 | 15.4% |
| 2020 | 5 | 9.6% |
| 2021 | 4 | 7.7% |
| 2022 | 1 | 1.9% |
Top 15 of 18 technology areas
Overall rank by patents
#6,455
of 50,000 tracked assignees
38.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.